Adherium announced a capital raise of up to $8.4 million to support US commercialisation of its Hailie Smartinhaler technology.
The plan includes a $1.6 million placement and a $6.8 million entitlement offer.
Funds will fuel research, product development, and market expansion in the US, following Food and Drug Administration clearances and reimbursement codes.
The company aims to accelerate US commercialisation and strengthen its global leadership in digital health solutions.